@hemedoc.bsky.social
Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, HLH, MRD, post-HCT relapse, GVHD, & immune recon. Photos (Instagram): pyknosis
@majorajay.bsky.social
Lymphoma/CLL faculty at the University of Colorado School of Medicine. Patient-reported outcomes methodologist & #lymsm quality of life investigator. #medsky
@vincentrk.bsky.social
Editor in Chief, Blood Cancer Journal; Professor, Mayo Clinic; Associate Editor, Mayo Clinic Proceedings; Oncologist, Cancer Research, Myeloma.
@drmiguelperales.bsky.social
Chief Adult BMT MSKCC | Past-President ASTCT | Past Board Member NMDP | Chair Committee Transplant/Cell Ther ALLIANCE | Immigrant 🇪🇸🇬🇧 #MedSky Opinions mine/not MSK https://www.mskcc.org/cancer-care/doctors/miguel-angel-perales
@rubenmesamd.bsky.social
President, Atrium Health Levine Cancer; Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center; Vice Dean - Cancer Wake Forest School of Medicine; SVP Atrium Health
@andrew02114.bsky.social
Medical oncologist at MGH Cancer Center, Asst. Prof. of Medicine, Harvard Medical School, focusing on patient care and trials in multiple myeloma and plasma cell disorders.
@lymphomadoc.bsky.social
Professor @mdanderson.bsky.social , Lead of Lymphoma/Myeloma Service Line, Director of Clinical Research, Section Chief of Aggressive/Indolent Lymphomas, Opinions mine
@ireneghobrial.bsky.social
Physician Scientist. Interested in early detection and interception in myeloma.
@craigthemyelomadoc.bsky.social
Myeloma Doctor at Karmanos Cancer Institute-Associate Professor at WayneState and MichiganState Universities
@lisagreaves.bsky.social
Vice President, Education @ASCO. DC native. Poet. Breast cancer survivor. Views are my own.
@mtmdphd.bsky.social
Views my own. VP Clinical Partnerships @TempusAI #PrecisionMedicine #mmsm #lymsm #CCC19 @COVID19nCCC @ASCO COI: https://coi.asco.org/share/RBB-TT6R/Michael
@jthjournal.bsky.social
The Journal of Thrombosis and Haemostasis (JTH) is the official journal of the ISTH. The mission of JTH is to advance science related to the important medical problems of thrombosis, bleeding disorders and vascular biology. #MedSky #HemeSky #CardioSky
@isth.org
The ISTH (nonprofit) offers a variety of educational programs & events for those who have a scientific interest in thrombosis, hemostasis & vascular biology.
@heme-fan.bsky.social
Classical hematologist with a focus on individuals with bleeding & clotting disorders. Dabbling in health services research.
@mdanderson.bsky.social
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Our mission: #EndCancer. Appointments available: 1-877-632-6789
@n8pennell.bsky.social
Professor and thoracic oncologist, ASCO Educational Book Editor in Chief, Vice Chair of Clinical Research, Cleveland Clinic Taussig Cancer Center. Dad, dogs and cats living together, Steeler and Tarheel fan. All opinions mine. #Medsky #LCSM #Oncsky
@jameabraham.bsky.social
Enterprise Chair, Department of Hematology and Medical Oncology, Cleveland Clinic; Deputy Editor @ASCOPost and JCO Oncology Practice- Opinions are my own - Believes in humanity, science and kindness! #breastcancer doc #Medsky #Oncsky
@brittanyeharvey.bsky.social
Clinical Practice Guidelines @ ASCO. Washington, DC. Opinions mine. She/Her.
@joshuafein.bsky.social
@anand-88-patel.bsky.social
Leukemia & myeloid malignancy doctor. posts=mine. Repost≠endorsement. He/him. https://scholar.google.com/citations?user=kNhjy-MAAAAJ&hl=en
@bidmc-cancercenter.bsky.social
We better the lives of patients with cancer, leveraging transformative science and pioneering therapies to provide highly personalized and compassionate care accessible to all.
@yalecancer.bsky.social
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians at Yale University and Smilow Cancer Hospital.
@penncancer.bsky.social
Penn Medicine - Abramson Cancer Center has proudly been an NCI-designated Comprehensive Cancer Center since 1973.
@hemasphere-journal.bsky.social
The official open access journal of EHA - we publish basic, translational, & clinical heme research. Ranked #7 of heme journals; 2023 Impact Factor = 11.9. #hematology #ScientificPublishing #BloodSky #HemeSky 👓 hemaspherejournal.com
@bsochaem.bsky.social
#BSH is the largest UK organisation for #haematology professionals, covering all sides of the specialty & transforming the care our members provide since 1960
@cancerdataedin.bsky.social
The Edinburgh Cancer Informatics Research Group. Using data to improve the care of cancer patients across South East Scotland. https://cancer-data.ecrc.ed.ac.uk/
@drkamarajk.bsky.social
Consultant in Clinical Haematology with special interest in Myeloma Stem Cell Transplant Cellular Therapy Infections as well as Research and development. Member of UKRD leadership team.
@juliperezbot.bsky.social
Platelet enthusiast and laboratory diagnostician @MayoClinic 🌈 🐱 & 🐶person #Medsky #Platelets #Pets
@ckbrierley.bsky.social
Academic Clinical Lecturer in Haematology, Oxford. Interested in all things myeloid disease and cellular therapy.
@rahulbanerjeemd.bsky.social
Assistant Professor at Fred Hutch Cancer Center (Seattle, WA, USA) specializing in multiple myeloma #MMsm and CAR-T therapy. My research focus: improving the patient experience in myeloma. COI: https://coi.asco.org/share/VU2-FHC3/Rahul%20Banerjee
@nicogagelmann.bsky.social
Hematologist. Academic. Train. Think. Let's create and integral and loving actuality.
@ash.hematology.org
The American Society of Hematology (ASH) is the world's largest professional society concerned with the causes and treatments of blood disorders. #Hematology #MedSky #BloodSky #HemeSky #HemeOnc 🩸 hematology.org
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: support@bsky.app